The role of asymmetric and symmetric dimethylarginines in renal disease
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The role of asymmetric and symmetric dimethylarginines in renal disease
Authors
Keywords
-
Journal
Nature Reviews Nephrology
Volume 7, Issue 5, Pages 275-285
Publisher
Springer Nature
Online
2011-03-29
DOI
10.1038/nrneph.2011.31
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Crosstalk between Arg 1175 methylation and Tyr 1173 phosphorylation negatively modulates EGFR-mediated ERK activation
- (2011) Jung-Mao Hsu et al. NATURE CELL BIOLOGY
- Dimethylarginine Dimethylaminohydrolase Overexpression Ameliorates Atherosclerosis in Apolipoprotein E-Deficient Mice by Lowering Asymmetric Dimethylarginine
- (2010) Johannes Jacobi et al. AMERICAN JOURNAL OF PATHOLOGY
- Review article: Asymmetric dimethylarginine as a mediator of vascular dysfunction and a marker of cardiovascular disease and mortality: an intriguing interaction with diabetes mellitus
- (2010) Maike Anderssohn et al. Diabetes & Vascular Disease Research
- Asymmetric dimethylarginine as an independent risk marker for mortality in ambulatory patients with peripheral arterial disease
- (2010) R. H. Böger et al. JOURNAL OF INTERNAL MEDICINE
- A methyl transferase links the circadian clock to the regulation of alternative splicing
- (2010) Sabrina E. Sanchez et al. NATURE
- Methylarginines and mortality in patients with end stage renal disease: A prospective cohort study
- (2009) Filippo Aucella et al. ATHEROSCLEROSIS
- Symmetric dimethylarginine predicts all-cause mortality following ischemic stroke
- (2009) Friedrich Schulze et al. ATHEROSCLEROSIS
- A study of endothelial function and circulating asymmetric dimethylarginine levels in people with Type 1 diabetes without macrovascular disease or microalbuminuria
- (2009) Latika Sibal et al. Cardiovascular Diabetology
- Vascular Endothelial-Specific Dimethylarginine Dimethylaminohydrolase-1–Deficient Mice Reveal That Vascular Endothelium Plays an Important Role in Removing Asymmetric Dimethylarginine
- (2009) Xinli Hu et al. CIRCULATION
- Plasma Asymmetric Dimethylarginine and Incidence of Cardiovascular Disease and Death in the Community
- (2009) Rainer H. Böger et al. CIRCULATION
- Dimethylarginines and inflammation markers in patients with chronic kidney disease undergoing dialysis
- (2009) Yildiz Oner-Iyidogan et al. CLINICAL AND EXPERIMENTAL MEDICINE
- Distribution of Asymmetric Dimethylarginine among 980 Healthy, Older Adults of Different Ethnicities
- (2009) K. Sydow et al. CLINICAL CHEMISTRY
- Asymmetric Dimethylarginine and Mortality in Stages 3 to 4 Chronic Kidney Disease
- (2009) J. M. Young et al. Clinical Journal of the American Society of Nephrology
- Asymmetrical dimethylarginine is associated with renal and cardiovascular outcomes and all-cause mortality in renal transplant recipients
- (2009) Sadollah Abedini et al. KIDNEY INTERNATIONAL
- Circulating methylarginine levels and the decline in renal function in patients with chronic kidney disease are modulated by DDAH1 polymorphisms
- (2009) Ben Caplin et al. KIDNEY INTERNATIONAL
- Protein Arginine Methylation in Mammals: Who, What, and Why
- (2009) Mark T. Bedford et al. MOLECULAR CELL
- Extensive characterization of the human DDAH1 transgenic mice
- (2009) Edzard Schwedhelm et al. PHARMACOLOGICAL RESEARCH
- The physiological and pathophysiological role of PRMT1-mediated protein arginine methylation
- (2009) Thomas B. Nicholson et al. PHARMACOLOGICAL RESEARCH
- Role of the PRMT–DDAH–ADMA axis in the regulation of endothelial nitric oxide production
- (2009) Arthur J. Pope et al. PHARMACOLOGICAL RESEARCH
- Polymorphisms in the promoter region of the dimethylarginine dimethylaminohydrolase 2 gene are associated with prevalence of hypertension
- (2009) Renke Maas et al. PHARMACOLOGICAL RESEARCH
- Dimethylarginine Dimethylaminohydrolase-1 Transgenic Mice Are Not Protected from Ischemic Stroke
- (2009) Frank Leypoldt et al. PLoS One
- A critical review and discussion of analytical methods in the l-arginine/nitric oxide area of basic and clinical research
- (2008) Dimitrios Tsikas ANALYTICAL BIOCHEMISTRY
- Impact of Asymmetric Dimethylarginine on Mortality After Acute Myocardial Infarction
- (2008) Marianne Zeller et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Asymmetric Dimethylarginine Independently Predicts Fatal and Nonfatal Myocardial Infarction and Stroke in Women
- (2008) Tora Leong et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- HPLC analysis of asymmetric dimethylarginine (ADMA) and related arginine metabolites in human plasma using a novel non-endogenous internal standard
- (2008) Scott Blackwell et al. CLINICA CHIMICA ACTA
- ADMA Levels Correlate with Proteinuria, Secondary Amyloidosis, and Endothelial Dysfunction
- (2008) M. I. Yilmaz et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Blood content of asymmetric dimethylarginine: new insights into its dysregulation in renal disease
- (2008) S. S. Billecke et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Role of symmetric dimethylarginine in vascular damage by increasing ROS via store-operated calcium influx in monocytes
- (2008) E. Schepers et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Response of Asymmetric Dimethylarginine to Hemodialysis-Associated Hypotension in End-Stage Renal Disease Patients
- (2008) Botond Csiky et al. NEPHRON CLINICAL PRACTICE
- Methylated arginine derivatives in children and adolescents with chronic kidney disease
- (2008) Ellen R. Brooks et al. PEDIATRIC NEPHROLOGY
- Role of asymmetric dimethylarginine for angiotensin II-induced target organ damage in mice
- (2007) Johannes Jacobi et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search